Blog
RSS FeedPosted by Michael Wonder on 27 Mar 2019
Charging for technology appraisals and highly specialised technologies
27 March 2019 - From 1 April 2019 NICE will charge for technology appraisal and highly specialised technologies assessments. ...
Posted by Michael Wonder on 27 Mar 2019
NICE recommendation for Steglatro in type 2 diabetes mellitus
27 March 2019 - NICE has recommended MSD’s Steglatro (ertugliflozin) for use within the NHS, for the treatment of adults ...
Posted by Michael Wonder on 26 Mar 2019
NICE at 20
26 March 2019 - Cost effectiveness body should stick to what it’s good at. ...
Posted by Michael Wonder on 25 Mar 2019
Pharma fears “lack of focus” on no-deal Brexit preparations
22 March 2019 - As Brexit is delayed, pharma suggests new measures to avoid no-deal drugs shortages. ...
Posted by Michael Wonder on 23 Mar 2019
NICE nod for Takeda’s Adcetris in advanced stage CTCL
22 March 2019 - Takeda has announced the NICE recommendation of its advanced cutaneous T-cell lymphoma drug Adcetris (brentuximab vedotin). ...
Posted by Michael Wonder on 21 Mar 2019
NICE terminates yet another assessment of a cancer medicine
20 March 2019 - This time it is pembrolizumab (Keytruda). ...
Posted by Michael Wonder on 21 Mar 2019
Is Orkambi deal close? Vertex meets again today with NHS England
21 March 2019 - Campaigners hopes rise after three year wait. ...
Posted by Michael Wonder on 20 Mar 2019
York man Paul Thomas-Peter says he could die because NHS won't fund drug
19 March 2019 - A York cancer patient says he could die because the NHS refuses to fund immunotherapy treatment ...
Posted by Michael Wonder on 20 Mar 2019
Unprecedented drug shortage linked to Brexit, NHS bosses say
20 March 2019 - Hospitals across England are experiencing medicine shortages due to "stockpiling and price pressure as the Brexit ...
Posted by Michael Wonder on 20 Mar 2019
The shadow of Brexit on speed of access
20 March 2019 - No-one can miss the ongoing saga that is the UK’s exit from the European Union. ...
Posted by Michael Wonder on 19 Mar 2019
NICE wants to stop saying ‘no’ – but needs pharma’s co-operation
18 March 2019 - Suggests Orkambi row has undermined confidence in NICE process. ...
Posted by Michael Wonder on 18 Mar 2019
CMA drops anti-competitive case against MSD
18 March 2019 - The Competition and Markets Authority has closed its investigation into a suspected anti-competitive discount scheme developed ...
Posted by Michael Wonder on 18 Mar 2019
NICE celebrates its 20th anniversary
18 March 2019 - Organisation was founded in April 1999 to improve outcome for health service users ...
Posted by Michael Wonder on 14 Mar 2019
One in four cancer patients wait two months for treatment, as NHS performance hits record low
14 March 2019 - The number of cancer sufferers waiting at least two months for treatment after an urgent referral ...
Posted by Michael Wonder on 14 Mar 2019
An EU wide approach to HTA: an irrelevant development or an opportunity not to be missed?
14 March 2019 - An EU-wide cooperation on HTA has been proposed recently by the European Commission, focusing on relative effectiveness ...